As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s health policy and working to create an efficient and affordable healthcare system in the long term. PharmaBoardroom recently sat down with the FOPH’s newly appointed director-general Anne Lévy to discuss starting such an important role amid a pandemic, her strategic priorities beyond COVID-19, and ensuring affordable access to innovative treatments in Switzerland.
By working together, we - the pharmaceutical industry, the health insurers and the FOPH - can create rapid, equal access to reimbursement for innovative drugs at affordable prices for all patients in Switzerland
